CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Open-market sale EVP and General Counsel sold 7,000 shares at $22.77 ($159,390)
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 3,119 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Technical Officer gave up 9,657 shares (to pay taxes)
- 4 Grant or award Chief Technical Officer acquired 5,984 shares (grant or award)
- 4 Shares withheld for taxes EVP and General Counsel gave up 734 shares (to pay taxes)
- 4 Open-market sale Director sold 50,075 shares at an average $25.30 ($1,266,774)
- 4 Open-market sale President and CEO sold 64,768 shares at an average $22.67 ($1,468,425)
- 4 Open-market sale Chief Technical Officer sold 18,235 shares at an average $22.60 ($412,169)
- 4 Open-market sale EVP & Chief Commercial Officer sold 7,898 shares at an average $25.21 ($199,132)
- 4 Shares withheld for taxes EVP and General Counsel gave up 5,858 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Officer gave up 7,144 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 23,786 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 8,491 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 2,300 shares (to pay taxes)
- 4/A Grant or award President and CEO acquired 133,989 shares (grant or award)
- 4/A Grant or award Chief Technology Officer acquired 51,889 shares (grant or award)
- 4/A Grant or award EVP & Chief Commercial Officer acquired 51,945 shares (grant or award)
- 4/A Grant or award Executive Vice President & CFO acquired 50,161 shares (grant or award)
- 4/A Open-market sale EVP and General Counsel sold 6,081 shares at $24.45 ($148,680)
- 4/A Grant or award EVP and Chief Medical Officer acquired 39,147 shares (grant or award)
Page 9 of 21 · 415 filings